Tandem Diabetes Care (TNDM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,753 | -122,611 | -73,033 | -83,447 | -72,418 |
| Depreciation Amortization | 5,507 | 8,081 | 6,850 | 5,404 | 4,833 |
| Income taxes - deferred | -25 | N/A | N/A | N/A | N/A |
| Accounts receivable | -13,698 | -15,848 | -10,445 | 2,251 | -6,473 |
| Accounts payable and accrued liabilities | 8,910 | 1,641 | -1,953 | 3,234 | 3,355 |
| Other Working Capital | -12,349 | 8,461 | -16,109 | 112 | -4,964 |
| Other Operating Activity | 78,314 | 111,957 | 28,554 | 11,273 | 16,903 |
| Operating Cash Flow | $41,906 | $-8,319 | $-66,136 | $-61,173 | $-58,764 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -49,664 | -87,753 | 8,500 | 19,378 | 8,259 |
| PPE Investments | -19,541 | -2,986 | -5,718 | -8,930 | -5,764 |
| Sale Of Investment | 12,250 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -74 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -74 |
| Investing Cash Flow | $-56,955 | $-90,739 | $2,782 | $10,448 | $2,421 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 49,994 | N/A |
| Debt Repayment | N/A | -87,711 | N/A | N/A | N/A |
| Common Stock Issued | 24,207 | 31,966 | 570 | 2,321 | 3,393 |
| Other Financing Activity | 0 | 172,929 | 39,806 | 0 | 64,862 |
| Financing Cash Flow | $24,207 | $117,184 | $40,376 | $52,315 | $68,255 |
| Exchange Rate Effect | 191 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 41,826 | 23,700 | 46,678 | 45,088 | 31,176 |
| End Cash Position | 51,175 | 41,826 | 23,700 | 46,678 | 43,088 |
| Net Cash Flow | $9,349 | $18,126 | $-22,978 | $1,590 | $11,912 |
| Free Cash Flow | |||||
| Operating Cash Flow | 41,906 | -8,319 | -66,136 | -61,173 | -58,764 |
| Capital Expenditure | -19,541 | -2,986 | -5,718 | -8,930 | -5,764 |
| Free Cash Flow | 22,365 | -11,305 | -71,854 | -70,103 | -64,528 |